Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.

Karen L. Kotloff(University of Maryland, Baltimore), Myron M. Levine(University of Maryland, Baltimore)

PubMed

January 1, 1999

Cited by 1,263

Related Papers

Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial

|The Lancet Infectious Diseases|2015|215